Expertise in
13
conditions

Dr. Michael B. Denenberg

Pulmonary Medicine
Office
370 Herlong Ave Ste 200, 
Rock Hill, SC 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
13
conditions
Office
370 Herlong Ave Ste 200, 
Rock Hill, SC 

Overview

Michael Denenberg is a Pulmonary Medicine provider practicing medicine in Rock Hill, South Carolina.

Dr. Denenberg is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Emphysema, Bullae, Pleurisy, Pleural Effusion, and Advanced Bronchoscopy.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 7 clinical trials. Dr. Denenberg is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in SC

Hospital Affiliations

Piedmont Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Office
370 Herlong Ave Ste 200, Rock Hill, SC 29732

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
Enrollment Status: Terminated
Publish Date: December 03, 2025
Intervention Type: Drug
Study Drug: HZN-825
Study Phase: Phase 2
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of of Tiotropium Bromide Inhalation Solution in Subjects With COPD
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of of Tiotropium Bromide Inhalation Solution in Subjects With COPD
Enrollment Status: Completed
Publish Date: May 10, 2021
Intervention Type: Drug
Study Drug: Tiotropium Bromide Inhalation Solution
Study Phase: Phase 2
View 6 Less Clinical Trials

3 Total Publications

Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Journal: Respiratory medicine
Published: July 23, 2017
Similar Doctors
Expertise in
14
conditions
Dr. William F. Alleyne
Pulmonary Medicine
Expertise in
14
conditions
Dr. William F. Alleyne
Pulmonary Medicine
Referral may be required
Before you request

Carolina Pulmonary Physicians PA

124 Glenwood Dr, 
Rock Hill, SC 
 (2.4 miles away)
803-324-5280
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Alleyne is a Pulmonary Medicine provider practicing medicine in Rock Hill, South Carolina. Dr. Alleyne is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Asbestosis, Lung Nodules, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Alleyne is currently accepting new patients.

Expertise in
27
conditions
Dr. Ahmed I. Elnaggar
Pulmonary Medicine
Expertise in
27
conditions
Dr. Ahmed I. Elnaggar
Pulmonary Medicine
Referral may be required
Before you request

Duke Health Lake Norman Hospital

171 Fairview Rd, 
Mooresville, NC 
 (41.9 miles away)
704-660-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ahmed Elnaggar is a Pulmonary Medicine provider practicing medicine in Mooresville, North Carolina. Dr. Elnaggar is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Atypical Pneumonia, Hospital-Acquired Pneumonia, and Advanced Bronchoscopy. Dr. Elnaggar is board certified in American Board Of Internal Medicine - Critical Care Medicine, American Board Of Internal Medicine - Pulmonary Disease , American Board Of Internal Medicine - Internal Medicine , and American Board Of Sleep Medicine - Sleep Medicine . Dr. Elnaggar is currently accepting new patients.

Expertise in
32
conditions
Expertise in
32
conditions
Referral may be required

Carolina Pulmonary-Northeast Columbia

3016 Longtown Commons Dr Ste 405, 
Columbia, SC 
 (58.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

M Christopher-Marshall is a Pulmonary Medicine provider practicing medicine in Columbia, South Carolina. Dr. Christopher-Marshall is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Obstructive Sleep Apnea. Dr. Christopher-Marshall is currently accepting new patients.

Frequently Asked Questions about Dr. Michael B. Denenberg

How do I make an appointment with Dr. Michael B. Denenberg?

You can book an appointment with Dr. Michael B. Denenberg by calling their office at 803-980-5864. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael B. Denenberg a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael B. Denenberg is classified as an Distinguished expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael B. Denenberg specialize in?

While Dr. Michael B. Denenberg is a Pulmonary Medicine, they have specific expertise in Emphysema, Bullae, and Pleurisy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Michael B. Denenberg participate in research or clinical trials?

Yes. Dr. Michael B. Denenberg has published 3 articles and abstracts on conditions like Emphysema. You can view a list of Dr. Michael B. Denenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael B. Denenberg accept my insurance?

Dr. Michael B. Denenberg accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 803-980-5864 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Denenberg's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile